Qube Research & Technologies Ltd - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 206 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$3,508,072
+226.0%
114,568
+510.3%
0.02%
+66.7%
Q1 2022$1,076,000
+186.9%
18,773
+335.1%
0.01%
+80.0%
Q3 2021$375,000
+9.0%
4,315
+61.3%
0.01%
+25.0%
Q2 2021$344,000
+7.8%
2,675
-32.9%
0.00%
-20.0%
Q1 2021$319,0003,9860.01%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders